The top panel shows BCL6 and its corepressors acting as oncogenes in diffuse large B-cell lymphoma (DLBCL). The bottom panel shows mechanism of action of the retro-inverso BCL6 inhibitory peptide (BPI) in inhibiting lymphoma cell growth. Professional illustration by Debra T. Dartez.